|1.||Check, J H: 28 articles (01/2015 - 01/2005)|
|2.||Quevedo, João: 19 articles (08/2015 - 05/2006)|
|3.||Valvassori, Samira S: 14 articles (08/2015 - 05/2006)|
|4.||Cohen, R: 13 articles (01/2015 - 01/2009)|
|5.||Kapczinski, Flávio: 10 articles (06/2012 - 05/2006)|
|6.||Dal-Pizzol, Felipe: 9 articles (03/2013 - 05/2006)|
|7.||Varela, Roger B: 7 articles (08/2015 - 12/2011)|
|8.||Killgore, William D S: 7 articles (02/2012 - 09/2005)|
|9.||Katsoff, B: 6 articles (01/2014 - 01/2005)|
|10.||Balkin, Thomas J: 6 articles (02/2012 - 09/2005)|
|1.||Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/01/2014 - "The demonstration that aminopeptidase-like activity in red blood cell cytosol is responsible for the hydrolysis of LDX extends our understanding of the smooth and consistent systemic delivery of d-amphetamine by LDX and the long daily duration of efficacy of the drug in relieving the symptoms of attention-deficit/hyperactivity disorder. "
08/01/1999 - "The aim of this paper is to determine the efficacy of dexamphetamine in adult attention deficit hyperactivity disorder (ADHD) in a naturalistic setting. "
06/01/2011 - "However, there do not appear to be any published clinical studies that have characterized the behavioral and cardiovascular effects of intranasally administered d-amphetamine, which is commonly prescribed for Attention Deficit Hyperactivity Disorder. "
08/01/1999 - "A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder."
04/01/2015 - "Dexamphetamine (dAMPH) is a stimulant drug that is widely used recreationally as well as for the treatment of attention-deficit hyperactivity disorder (ADHD). "
|2.||Cocaine-Related Disorders (Cocaine Addiction)
05/01/2002 - "Sustained release dextroamphetamine (15-30 mg but not 30-60 mg) improved retention in patients with cocaine dependence."
04/01/2010 - "The results of preclinical laboratory experiments and clinical trials indicate that agonist replacements such as d-amphetamine may be a viable option for managing cocaine dependence. "
10/01/2009 - "Recent studies have investigated D-amphetamine as a potential agonist medication for cocaine dependence. "
01/01/2009 - "The results of preclinical laboratory studies and clinical trials indicate that agonist replacements like D-amphetamine may be a viable option for managing cocaine dependence. "
08/01/2003 - "Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence."
01/01/1977 - "Subsequent administration of d-amphetamine eliminated seizures, except at 4c, at which temperature only stereotyped behavior was observed. "
01/01/1983 - "Studies on the pharmacology of d-amphetamine on maximal electroconvulsive seizure in young chicks."
12/08/2000 - "Neuronal degeneration was detected in the tenia tecta and other regions of the anterior limbic system of male weanling rats 3 days after four doses of 5 mg/kg d-amphetamine (4 x 5 mg/kg AMPH) when seizures occurred during AMPH exposure. "
01/01/2000 - "Seizure was elicited after lethal doses of d-amphetamine (75 mg/kg, i.p.) administration in mice. "
10/26/1998 - "Neuronal degeneration in rat forebrain resulting from D-amphetamine-induced convulsions is dependent on seizure severity and age."
|4.||Weight Loss (Weight Reduction)
01/01/2015 - "Our treatment with dexamphetamine, diet, and exercise was well tolerated and effective for initial weight loss. "
05/04/2006 - "Although these subjects ingested approximately 50% of the amount of food ingested by free-feeding SHU9119-infused rats, they displayed no weight loss and no change in sensitivity to D-amphetamine. "
10/01/1980 - "The dextroamphetamine group was superior in terms of behavioral treatment participation, extent of eating and exercise habit change, and weight loss. "
02/01/1949 - "Dexedrine and weight reduction."
01/01/2015 - "The mean weight gain in the 6 months after ceasing dexamphetamine was 4.5 kg (95% CI 1.9-7.2, p = 0.003), leaving a mean weight loss at 12 months from baseline of 7.0 kg (95% CI -13.4 to -0.6, p = 0.03). "
01/01/2014 - "Marked improvement of pain from long-term fibromyalgia with dextroamphetamine sulfate in a woman who failed to improve with conventional pharmacologic treatment."
01/01/2015 - "Dextroamphetamine sulfate relieved pain from adenomyosis similar to its effect on endometriosis."
01/01/2014 - "Dextroamphetamine sulfate 20 mg daily was prescribed to a 45-year-old woman who complained of 20 plus years of severe stabbing retrorbital pain who was diagnosed with keratoconus but failed to gain relief from bilateral corneal implants. "
05/01/1986 - "Combinations of morphine and d-amphetamine have been shown to be more effective in relieving pathological and experimental pain with fewer side effects than morphine alone. "
01/01/2014 - "Dextroamphetamine sulfate, a very effective drug for pelvic pain relieved severe retroorbital stabbing pain in a woman with keratoconus who failed to respond to bilateral corneal implants."
|7.||Caffeine (No Doz)
|8.||Morphine (MS Contin)
|1.||Drug Therapy (Chemotherapy)
|4.||Speech Therapy (Therapy, Speech)
|5.||Activities of Daily Living (ADL)